Tomoko Ueda

407 total citations
23 papers, 310 citations indexed

About

Tomoko Ueda is a scholar working on Molecular Biology, Reproductive Medicine and Ophthalmology. According to data from OpenAlex, Tomoko Ueda has authored 23 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Reproductive Medicine and 4 papers in Ophthalmology. Recurrent topics in Tomoko Ueda's work include Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cellular transport and secretion (3 papers). Tomoko Ueda is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cellular transport and secretion (3 papers). Tomoko Ueda collaborates with scholars based in Japan, United States and China. Tomoko Ueda's co-authors include Hiroaki Shibahara, Hiroshi Tsubamoto, Kayo Inoue, Kazuko Sakata, Takashi Sonoda, Kazuhisa Nakayama, Hye‐Won Shin, Motohiro Kamei, Mihoko Suzuki and Senye Takahashi and has published in prestigious journals such as The EMBO Journal, FEBS Letters and Investigative Ophthalmology & Visual Science.

In The Last Decade

Tomoko Ueda

22 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomoko Ueda Japan	9	167	76	57	36	34	23	310
Alka Mahale United States	11	279 1.7×	72 0.9×	95 1.7×	78 2.2×	67 2.0×	16	469
M Kaufmann Germany	10	240 1.4×	40 0.5×	142 2.5×	9 0.3×	63 1.9×	16	406
Mohammed Benkheil Belgium	8	245 1.5×	43 0.6×	88 1.5×	8 0.2×	80 2.4×	8	443
Annamarie C. Dalton United States	10	282 1.7×	27 0.4×	94 1.6×	12 0.3×	55 1.6×	13	381
Aili Yang China	8	177 1.1×	16 0.2×	144 2.5×	13 0.4×	71 2.1×	22	396
Karen Jung Canada	12	220 1.3×	20 0.3×	106 1.9×	12 0.3×	91 2.7×	19	334
Martin Udart Germany	10	248 1.5×	28 0.4×	214 3.8×	10 0.3×	47 1.4×	15	428
Anoosheh Ebaee United States	4	233 1.4×	26 0.3×	132 2.3×	6 0.2×	51 1.5×	6	365
Zachary T. Kneass United States	4	265 1.6×	32 0.4×	82 1.4×	137 3.8×	26 0.8×	4	354

Countries citing papers authored by Tomoko Ueda

Since Specialization

Citations

This map shows the geographic impact of Tomoko Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Ueda more than expected).

Fields of papers citing papers by Tomoko Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Ueda. The network helps show where Tomoko Ueda may publish in the future.

Co-authorship network of co-authors of Tomoko Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Ueda. A scholar is included among the top collaborators of Tomoko Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Ueda. Tomoko Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ueda, Tomoko, Hiroshi Tsubamoto, Yumiko Nishimura, et al.. (2023). Comprehensive Genomic Profiling Detects Hereditary Cancers and Confers Survival Advantage in Patients With Gynaecological Cancers. Anticancer Research. 43(5). 2091–2101. 1 indexed citations

Ueda, Tomoko, et al.. (2022). Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study. Gynecologic Oncology Reports. 42. 101013–101013. 2 indexed citations

Tsubamoto, Hiroshi, Tomoko Ueda, Kayo Inoue, et al.. (2021). Itraconazole Inhibits Intracellular Cholesterol Trafficking and Decreases Phosphatidylserine Level in Cervical Cancer Cells. Anticancer Research. 41(11). 5477–5480. 2 indexed citations

Tsubamoto, Hiroshi, Kayo Inoue, Tomoko Ueda, et al.. (2021). Itraconazole Increases Resolvin E3 Concentration and 12/15-lipoxygenase Inhibitor Attenuates Itraconazole Cytotoxicity in Cervical Cancer Cells. Anticancer Research. 41(9). 4271–4276. 4 indexed citations

Inoue, Kayo, et al.. (2020). Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report. Gynecologic Oncology Reports. 32. 100563–100563.

Tsubamoto, Hiroshi, et al.. (2018). Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases. Gynecologic Oncology Reports. 24. 57–60. 5 indexed citations

Tsubamoto, Hiroshi, et al.. (2018). Effects of leuprorelin for the treatment of recurrent gynecological cancer by assessment including self‐administered quality‐of‐life questionnaire. Journal of obstetrics and gynaecology research. 45(1). 203–209. 3 indexed citations

Tsubamoto, Hiroshi, Kayo Inoue, Kazuko Sakata, et al.. (2017). Itraconazole Inhibits AKT/mTOR Signaling and Proliferation in Endometrial Cancer Cells. Anticancer Research. 37(2). 515–520. 33 indexed citations

Ueda, Tomoko, Hiroshi Tsubamoto, Kayo Inoue, et al.. (2017). Itraconazole Modulates Hedgehog, WNT/β-catenin, as well as Akt Signalling, and Inhibits Proliferation of Cervical Cancer Cells. Anticancer Research. 37(7). 3521–3526. 20 indexed citations

10.

Tsubamoto, Hiroshi, Tomoko Ueda, Kayo Inoue, et al.. (2017). Repurposing itraconazole as an anticancer agent. Oncology Letters. 14(2). 1240–1246. 83 indexed citations

11.

Tojo, Naoki, et al.. (2017). Results of the Baerveldt® Glaucoma Implant for Neovascular Glaucoma Patients.. PubMed. 121(2). 138–45. 6 indexed citations

12.

Ueda, Tomoko, et al.. (2016). Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma. Gynecologic Oncology Reports. 16. 11–13. 5 indexed citations

13.

Ueda, Tomoko, et al.. (2015). Class I Arfs (Arf1 and Arf3) and Arf6 are localized to the Flemming body and play important roles in cytokinesis. The Journal of Biochemistry. 159(2). 201–208. 18 indexed citations

14.

Ueda, Tomoko, et al.. (2015). Crowned dens syndrome: reports of six cases and review of the literature. Acute Medicine & Surgery. 3(2). 155–158. 5 indexed citations

15.

Hayashi, Atsushi, et al.. (2014). Observation of microcystic changes in the inner retina with adaptive optics fundus camera. Investigative Ophthalmology & Visual Science. 55(13). 2608–2608. 1 indexed citations

16.

Ueda, Tomoko, Keiji Kubo, Hiroyuki Sakagami, et al.. (2013). EFA6 activates Arf6 and participates in its targeting to the Flemming body during cytokinesis. FEBS Letters. 587(11). 1617–1623. 8 indexed citations

17.

Makyio, Hisayoshi, Senye Takahashi, Hiroyuki Takatsu, et al.. (2012). Structural basis for Arf6–MKLP1 complex formation on the Flemming body responsible for cytokinesis. The EMBO Journal. 31(11). 2590–2603. 48 indexed citations

18.

Ueda, Tomoko, et al.. (2010). Activated Protein C Rescues the Retina from Ischemia-Induced Cell Death. Investigative Ophthalmology & Visual Science. 52(2). 987–987. 26 indexed citations

19.

Miyara, Takayuki, et al.. (2006). [A case of acute pulmonary thromboembolism accompanied by anomalous inferior vena cava with azygous continuation].. PubMed. 44(12). 957–61. 2 indexed citations

20.

Sano, Hajime, Tomoko Ueda, Shunsei Hirohata, et al.. (1998). A case of severe neuropsy chiatric lupus erythematosus treated by plasmapheresis: Diagnostic values of serum antiribosomal P protein antibodies and interleukin-6 in cerebrospinal fluid.. Japanese Journal of Clinical Immunology. 21(4). 172–179. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact